December 2024 - Davis_members

Showcase Your Work: Submit Your Pathology Image for Our Next Cover!
by Images ＠ Davis-Thompson Foundation Dec. 30, 2024

Dec. 30, 2024

The Davis-Thomson Foundation invites you to submit digital gross, microscopic, or ultrastructural images depicting a lesion, to be featured on the front page of the monthly newsletter. Each month a new image will take pride of place in the issue. Worried about image copyrights? Have no fear, the foundation does not claim copyright for any material published by us. Submission information: · Submission deadline: submit anytime; all submissions roll over to be considered for future covers if we have already selected an image for the upcoming newsletter. · *Send your image by e-mail to: * o Dr. Kate Watson and Dr. Donald McGavin: images(a)davisthompsonfoundation.org Figure Requirements (see examples below): · Do not exceed the maximum file size of 5 MB. · Acceptable formats are TIFF and JPEG. · *Minimum acceptable resolution is 300 pixels/inch* (120 pixels/cm) o When you are saving a file such as a TIFF from any package such as Photoshop, you are given the option of compressing the file. LZW compression will speed up the upload and download times and will not affect your image in a negative way. Figure Legend provided within the email or as a word document attachment separate from the image file: · Name/names of contributors and their affiliated institutions. · Brief (no longer than 2 sentence) description of the lesion including: o Signalment o Diagnosis o Any other pertinent information you want to share Cheers, Drs. Kate Watson and Donald McGavin

1 0

Anatomic Pathologist - International Zoo Veterinary Group
by Bruce Williams Dec. 21, 2024

Dec. 21, 2024

*Veterinary Anatomic Pathologist: Aquatic, Zoo and Wildlife Species* *International Zoo Veterinary Group Pathology* *Keighley, United Kingdom* International Zoo Veterinary Group (IZVG) was founded in 1976 and is the largest freelance zoo medicine practice in the world, working exclusively with non-domestic species. IZVG Pathology was established in 2003 and provides dedicated anatomic pathology services for the practice’s zoo, aquarium and wildlife conservation work. IZVG Pathology works from our own fully equipped post- mortem facility and histology laboratory situated within IZVG’s main building in Keighley, West Yorkshire. Keighley is on the edge of the beautiful Yorkshire Dales and within easy travelling distance of the Lake District, and close to the larger cities of Leeds and Bradford. *The role: *Working alongside our existing principal veterinary pathologist, who will be your direct line manager, with two histology technicians, and supported by zoological medicine clinical specialists, you will take immediate responsibility for a caseload that comprises significant numbers of marine aquarium fish, non-domestic mammalian (particularly primate), avian, and lower vertebrate species, as well as invertebrates. Diagnostic histopathology will be a major part of your daily work, for IZVG’s own clients and for external clients including veterinary surgeons and referral laboratories. Necropsy examinations are also a frequent (typically daily) and irreplaceable feature of our work, occasionally necessitating travel off-site. A network of external collaborators enables us to source additional diagnostics as necessary. Opportunities exist for input into conservation projects in association with field biologists and vets. *The person:* MRCVS (or immediate eligibility) and a postgraduate qualification in Veterinary Pathology are essential (FRCPath, DipACVP, DipECVP or equivalent), as are robust diagnostic and communication skills. We are particularly seeking experience and enthusiasm for fish pathology, and experience with other non-domestic animal pathology would also be an advantage. Whatever your prior experience you will be expected to demonstrate a genuine interest and enthusiasm for aquatic species pathology and a willingness to develop relevant expertise rapidly, with a commitment to providing the best quality diagnostic service to our clients. Experience of research methods and a track record of publication would also be desirable. *Remuneration:* The post carries a competitive salary along with additional benefits including medical insurance. Relevant CPD is encouraged and funded and there are considerable in-house training resources. *Contact:* Informal enquiries are welcomed to the Principal Veterinary Pathologist Dr Mark Stidworthy by email (M.Stidworthy(a)izvg.co.uk) or telephone (01535 692000 (laboratory) or 07771 567506 (mobile)). Further job information and an application form can be found at: https://www.izvg.co.uk/practice/pnews.htm A completed application form, a cover letter briefly outlining experience and future goals and a curriculum vitae should be sent to: c.kelly(a)izvg.co.uk. The post is available from March 1st 2025 and the closing date for applications is 9 a.m. (GMT) on Friday February 7th 2025.

1 0

STP Annual meeting June 22-24 2024
by Bruce Williams Dec. 21, 2024

Dec. 21, 2024

Dear Colleagues, The Society of Toxicologic Pathology (STP) is seeking to broaden its membership by reaching out to scientists and students (veterinary/residents/graduate) involved or interested in safety assessment, teaching, or research in toxicologic pathology/toxicology and inviting them to join the STP and attend our 44th Annual Symposium: Toxicologic Neuropathology: Basics and Beyond, scheduled for June 22–25, 2025, at the Fairmont Chicago – Millennium Park in Chicago, Illinois. The symposium promises an exceptional opportunity to engage with leading experts, share insights, and deepen our understanding of critical topics in toxicologic neuropathology. To help us reach scientists and students at your institution with a variety of backgrounds and research interests, we kindly ask that you post our Annual Symposium (see below) in your departmental newsletter and/or continuing education section of your Website. Alternatively, please forward this information to the appropriate person or provide us with the contact information. Please note that there are several different opportunities for students to apply for monetary awards through the generous Student Awards program. The deadline for most awards is March 30. See individual award details for nomination/application and selection processes. Registration fees are waived for active STP student members. Nonmember students who apply by April 1 for STP student membership ($35 annual dues) and are approved can also register for free. In addition, nonmember meeting registrants who apply for membership by July 1 and are accepted will receive complimentary membership for the remainder of 2025. Please visit www.toxpath.org to apply for membership. Important Deadlines • Abstract Submission Deadline: March 30 • Student Awards Application Deadline: March 30 • Early Bird Registration Deadline: April 30 Student Awards and Grants (Deadline: March 30) ( http://www.toxpath.org/am2025/awards.asp) • Student Travel Grants • STP Young Investigator Awards • STP Environmental Toxicologic Pathology SIG Student Research Award • The Daniel Morton and Laura Dill Morton Scholarship (Deadline: November 1, 2025) • IATP/STP Charles Capen Trainee Award (Deadline: November 1, 2025)

1 0

Staff Scientist, National Institute of Environmental Health Sciences (NIEHS)
by Bruce Williams Dec. 20, 2024

Dec. 20, 2024

Department of Health and Human Services National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Division of Translational Toxicology (DTT) Research Triangle Park, North Carolina Staff Scientist Comparative and Molecular Pathogenesis Branch (CMPB) The National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC is seeking a dynamic, highly motivated Staff Scientist to support the Comparative and Molecular Pathogenesis Branch, CMPB in the Division of Translational Toxicology, formerly known as the Division of the National Toxicology Program (DNTP). The mission of the DTT is to improve public health through data and knowledge development that are translatable, predictive, and timely. The DTT provides critical data for regulatory and non-regulatory stakeholder decision making to protect human health using epidemiological data, in vivo studies, alternative in vivo model systems, in vitro high-throughput screens and/or computational approaches. To achieve its mission, DTT scientists 1) collaborate with public stakeholders and global partners to identify and address public health issues, 2) generate and communicate trusted information to support decision making on environmental hazards, 3) lead the transformation of toxicology in the development and application of innovative tools and strategies, and 4) educate and train the next generation of translational toxicologists. DTT’s scientific goals are achieved through a distinct, highly cooperative and integrated team science operational model whereby scientific staff across multiple branches assemble into interdisciplinary project teams and utilize centrally managed shared resources, in contrast to the traditional NIH principal investigator-led research group model. The majority of research is carried out through use of external research and development contracts together with onsite intramural research capability. CMPB is a key contributor to DTT’s efforts to lead the science of toxicology and environmental public health by providing toxicologic pathology leadership and laboratory animal medicine expertise to meet the goals of the DTT using new technologies in biomedical research. A major function of the Branch is to provide a translational and mechanistic context to pathology outcomes with the integration of scientific data across all DTT branches and offices. In addition, CMPB trains pathology and laboratory animal medicine fellows to be leaders in multidisciplinary research. CMPB scientists and staff are responsible for the following general functions: developing new methods, approaches, and technologies in pathology and laboratory animal medicine. In addition, the Branch directs, manages, evaluates, and interprets all pathology data generated during the conduct of DTT toxicity and carcinogenicity studies, directs the DTT laboratory animal medicine program, establishes standards, terminology, and diagnostic criteria for rodent pathology, investigates molecular mechanisms of spontaneous and chemically induced nonneoplastic and neoplastic lesions in DTT studies, leads state-of the-science core pathology laboratories, oversees the scientific activities of the DTT archives and frozen tissue bank, provides diagnostic pathology expertise and collaborations with NIEHS investigators and the NIEHS laboratory animal colony. Roles and Responsibilities: NIEHS is seeking a staff scientist for Mouse Embryo Phenotyping (MEP) group within CMPB, in DTT, at NIEHS. MEP work is project-driven and supports divisional interdisciplinary investigators to advance its mission of providing broad support and training in mouse embryo phenotyping techniques in support of the NIEHS vision and mission. The scientific goals for MEP are achieved through a distinct and highly cooperative and integrated team science operational model, providing project assistance through the utilization of shared NIEHS Core facilities. A principal role for this position is to assist NIEHS investigators in assigning molecular underpinnings to developmental phenotypes encountered in genetically modified mouse models. The staff scientist will manage and be the lead contact for all project submissions to the MEP group. The staff scientist partners with a team consisting of a histologist and pathologist with expertise in developmental biology, tissue handling and pathology tailored to embryo phenotyping of genetically engineered mice under study. Additionally, the MEP staff scientist collaborates across the Institute to stay abreast of novel approaches and best practices for the integration of information technology and other solutions that may serve to scientifically advance projects submitted to the MEP group. As a NIH Title 42(g) Staff Scientist 1, the employee is generally appointed to a time-limited, renewable position. Staff Scientists do not receive independent resources as a principal investigator, although they will often work independently and have sophisticated skills and knowledge essential to the work of the branch. Qualifications: The ideal candidate will have a research-based professional degree (Ph.D., M.D., Pharm.D., D.V.M., or equivalent) in the life sciences. The candidate will have experience in developmental biology, the generation of genetically engineered mice and mouse embryo phenotyping. In addition, the candidate will have demonstrated a strong working knowledge of histology, pathology, molecular biology, molecular genetics, cellular biology, systems biology, and Next Generation Sequencing. As manager, the candidate must take a lead role in guiding and collaborating with NIEHS investigators in the discovery of a phenotype. The candidate should have knowledge and the ability to recommend to investigators and participate in advanced molecular techniques (e.g., spatial transcriptomics) that have the potential to aid in understanding the phenotype and advancing the project. The candidate must have strong leadership, organizational and communication skills to successfully manage the Core, advise, and instruct NIEHS trainees on how to move forward with their respective projects, and to provide advice to senior staff with respect to core facility expertise and operations. At the supervisor’s discretion, this position may offer work schedule flexibilities. These flexibilities may be requested in accordance with the HHS Workplace Flexibilities policy. https://www.hhs.gov/about/agencies/asa/ohr/hr-library/990-1/index.html Appointee may be a US citizen, Legal Permanent Resident of non-US citizen who is eligible for a valid work authorization. This position is subject to a background investigation. Salary and benefits: This is a federal full-time equivalent position, and a comprehensive benefits package is available. Salary will be commensurate with experience, qualifications, and accomplishments. How to apply: *Interested candidates should submit materials as one combined PDF via email to DTTPersonnelMgmt(a)niehs.nih.gov <DTTPersonnelMgmt(a)niehs.nih.gov>. All emails should include vacancy number NR#504 in the subject line. Review of applications will begin after January 18, 2025. * A complete application package must include: • Cover Letter: Include statement of interest, research experience and goals (3-page max). • Curriculum Vitae: Include full CV and Bibliography, including examples of scientific recognition (e.g., awards, honors, and outside activities). • DEIA Statement: Include a statement that addresses your commitment to Diversity, Equity, Inclusion, and Accessibility. In addition, you must arrange for two letters of reference from individuals in the scientific/academic community who are familiar your accomplishments, motivation, and skills (within one year of application) to be sent directly to DTTPersonnelMgmt(a)niehs.nih.gov. Letters should be on official letterhead, signed, and dated. Referees must include the applicant’s name and vacancy number NR504 in the email subject line. Incomplete or paper applications will not be accepted or evaluated. *For further information about the position, please contact Dr. Angela King-Herbert at DTTPersonnelMgmt(a)niehs.nih.gov <DTTPersonnelMgmt(a)niehs.nih.gov>. * Commitment to Diversity and Equal Employment Opportunity: NIH, NIEHS encourages the application and nomination of traditionally underrepresented groups in the sciences, including women, minorities, and individuals with disabilities. The United States Government does not discriminate in employment on the basis of race, color, religion, sex (including pregnancy and gender identity), national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, membership in an employee organization, retaliation, parental status, military service, or other non-merit factors. NIH, NIEHS will provide reasonable accommodations to applicants with disabilities as appropriate. If you require reasonable accommodation during any part of the application and hiring process, please notify us. Equal Opportunity Employment: Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. NIH encourages the application and nomination of qualified women, minorities, and individuals with disabilities. Foreign Education: Applicants who have completed part or all of their education outside of the United States must provide an evaluation by an accredited organization to ensure its equivalence to education received in accredited educational institutions in the United States. For more information on foreign education verification, visit the National Association of Credential Evaluation Services (NACES) website at http://www.naces.org/. Verification must be received prior to the effective date of the appointment. NIH is the premier biomedical research center for the world. Its 27 institutes and centers employ more than 21,000 employees doing a vast array of jobs, all supporting efforts for a healthy nation. For information about the NIH mission, goals and institutes and centers, visit https://www.nih.gov/about-nih. DO NOT INCLUDE YOUR BIRTH DATE, PHOTOGRAPH, OR SOCIAL SECURITY NUMBER (SSN) ON APPLICATION MATERIALS. DHHS AND NIH ARE EQUAL OPPORTUNITY EMPLOYERS

1 0

DTF-LCPG # 251 – Question Sheet
by Claudio Barros Dec. 15, 2024

Dec. 15, 2024

Dear All, Attached is the Question Sheet for Diagnostic Exercise* # 251*, contributed by Ariadni Kotzias Bandeira1, Silvio C. Fonseca1, and Fábio S. Mendonça1 1Laboratory of Animal Diagnosis, Federal Rural University of Pernambuco, Recife, PE, Brazil. Corresponding author: fabio.mendonca(a)ufrpe.br This is our last postage of the year. I hope you have a Merry Christmas and a Prosperous New Year! Lots of love, happiness, sanity, and a strong drink. Claudio

1 0

DTF-LCPG # 250 – Answer sheet
by Claudio Barros Dec. 15, 2024

Dec. 15, 2024

Dear All, I've attached the answer sheet for Diagnostic Exercise *#250*, contributed by Anderson H. Gris1, Paola Sônego1, Emanoelly M. S. Silva1, Claudio S. L. Barros2, and David Driemeier1, 1Setor de Patologia Veterinária, Faculdade de Medicina Veterinária, Universidade Federal do Rio Grande do Sul (SPV-UFRGS), Porto Alegre, RS, Brazil. 2Laboratório de Anatomia Patológica, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil. Corresponding author: anderson_gris(a)hotmail.com.br This is our last postage of this year. I hope you have a Merry Christmas and a Prosperous New Year! Lots of love, happiness, sanity, and a strong drink. Claudio

1 0

RVC & Finn Pathologists (UK) residency
by Francisco Alejandro Uzal Dec. 11, 2024

Dec. 11, 2024

RVC & Finn Pathologists are opening a residency position. Application deadline is Jan 19. More info here: https://www.careerswithcvs.co.uk/jobs/vacancy/anatomic-pathology-trainee-re… Best regards Francisco Uzal, DVM, MSc, PhD, Dipl. ACVP Chief Executive Officer Davis-Thompson Foundation Ph: 951 751 0027 E-mail: fauzal(a)ucdavis.edu<mailto:fauzal@ucdavis.edu> www.davisthompsonfoundation.org<https://www.davisthompsonfoundation.org/> [https://drive.google.com/uc?id=1oticUQZYjDPU-1vMA4wHKvLb2SScHV-J]

1 0

Gen Path course: registration is OPEN!
by Jey Koehler Dec. 3, 2024

Dec. 3, 2024

Hey everyone, if you are interested in digging into gen path, boy have we got a deal for you. Imagine a team of eight of the smartest people you know who've gone through the books and boiled down the really good stuff into bite-sized pieces for you. Now imagine you can nomnom on this delicious knowledge pie in the comfort of you own home in your PJs! Registration for the D-TF Gen Path course is now available, so find out more and register here: https://davisthompsonfoundation.org/event/2025-general-pathology-review-cou… Hope to see you there (or an avatar anyway). Jey Koehler, DVM, PhD, Dipl. ACVP Professor and Tyler & Frances Young Endowed Chair in Pathology Auburn University College of Veterinary Medicine President, Davis-Thompson Foundation www.davisthompsonfoundation.org<http://www.davisthompsonfoundation.org/>

1 0

Davis-Thompson Foundation Newsletter December 2024
by Francisco Alejandro Uzal Dec. 1, 2024

Dec. 1, 2024

Dear colleagues I am proud to share with you the December issue of the Davis-Thompson Foundation (DTF) Newsletter, once again, masterfully prepared by our Managing Editors, Javier Asin and Jeann Leal. Thank you Javier and Jeann!!!!. This is a particularly large issue, with a huge amount of information on recent and future activities of the Foundation. The first order is to congratulate all the trainees and pathologists who received awards during the DTF Award Ceremony at the recent ACVP annual meeting in Seattle. Well done everyone! And special thanks to our volunteers who organized such a wonderful reception! Continuing with the ACVP meeting, the Foundation had, as usual, a very strong presence during the conference, and provided a robust list of training and network opportunities for everyone. This included, but was not limited to, the Pre-Meeting workshop on Gastrointestinal tumors, the two half days of the face-to-face session of the outstanding Foundations of Pathology course, the Scientific session of the Latin Comparative Pathology Group, the meeting of the Board of Directors of the Foundation and much more. And once again, all these activities were organized and carried out by our outstanding volunteers. Please remember them to say thanks every time you meet them. Looking forward to seeing you in one of our training activities. Warm regards. Francisco Uzal, DVM, MSc, PhD, Dipl. ACVP Chief Executive Officer Davis-Thompson Foundation Ph: 951 751 0027 E-mail: fauzal(a)ucdavis.edu<mailto:fauzal@ucdavis.edu> www.davisthompsonfoundation.org<https://www.davisthompsonfoundation.org/> [https://drive.google.com/uc?id=1oticUQZYjDPU-1vMA4wHKvLb2SScHV-J]

1 0

DTF-LCPG # 249 – Answer sheet
by Claudio Barros Dec. 1, 2024

Dec. 1, 2024

Dear All, Attached is the Answer sheet for Diagnostic Exercise #249 contributed by Tessie B.M. Möck, Carolina C. Guizelini, Rayane C. Pupin, Ricardo A.A. de Lemos, Danilo C. Gomes, Claudio S.L. Barros. Laboratório de Anatomia Patológica, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil. Corresponding author: tessiebeck(a)hotmail.com Best Regards Claudio The Diagnostic Exercises are an initiative of the Latin Comparative Pathology Group (LCPG), the Latin American subdivision of The Davis-Thompson Foundation. These exercises are contributed by members and non-members from any country of residence. Please consider contributing a case to this initiative. It does not have to be unusual, and all sub-specialties of pathology are welcome! Please consult instructions on how to format and submit your DE at https://davisthompsonfoundation.org/diagnostic-exercises-instructions/ Previous cases are available at https://davisthompsonfoundation.org/diagnostic-exercise/

1 0